What is the appropriate treatment approach for bladder spasms in an adult patient?

Treatment of Bladder Spasms in Adults

For bladder spasms in adults, initiate anticholinergic medications (such as oxybutynin or trospium chloride) as first-line pharmacotherapy, with consideration for non-pharmacological interventions including catheter balloon volume adjustment and transcutaneous electrical nerve stimulation for catheter-associated spasms.

Clinical Context and Etiology

Bladder spasms occur in two primary clinical scenarios that require different management approaches:

• Catheter-associated spasms: Following urologic procedures or in patients with indwelling catheters
• Overactive bladder (OAB) syndrome: Characterized by urgency, frequency, and nocturia with or without incontinence 1, 2

The incidence of postoperative bladder spasms is substantial—approximately 343 per 1,000 procedures after cystoscopic interventions, with higher rates (>40%) following more extensive procedures like transurethral resection 3.

First-Line Pharmacological Management

Anticholinergic Therapy

Anticholinergics remain the cornerstone of bladder spasm treatment 4, 5:

• Trospium chloride (Spasmex) is particularly advantageous because it does not cross the blood-brain barrier, avoiding central nervous system adverse effects while maintaining efficacy 5
• Oxybutynin is commonly used for acute postoperative spasms 3
• Flexible dosing allows individualized titration based on response and tolerability 5

Alternative Pharmacological Options

For patients who fail or cannot tolerate anticholinergics 4:

• β3-adrenergic agonists (mirabegron, vibegron)
• Solifenacin for short-term symptom relief
• Ketamine in specific perioperative contexts
• Vitamin C has shown some efficacy

Non-Pharmacological Interventions

Nursing-Led and Physical Interventions

Non-pharmacological approaches should be prioritized alongside medications, particularly for catheter-associated spasms 6:

• Catheter balloon volume adjustment: Reducing balloon volume can significantly decrease spasm frequency
• Transcutaneous electrical nerve stimulation (TENS) of the foot: Stimulating somatic afferent nerves for 60 minutes daily reduces Visual Analogue Scale pain scores and total symptom burden by day 2-3 postoperatively 7
• Evidence-based targeted nursing care protocols consistently reduce symptom severity 6

Important Caveat on Prophylaxis

Belladonna and opium (B&O) suppositories, despite widespread use, showed no significant reduction in bladder spasm rates (OR 0.91, p=0.318) in a large cohort study 3. This challenges traditional prophylactic approaches.

Risk Stratification

Identify high-risk patients who require more aggressive management 8:

• Higher International Prostate Symptom Score (IPSS) preoperatively (P=0.009)
• Lower educational levels (associated with increased spasm risk)
• Preoperative anxiety (predicts catheter-related bladder discomfort)
• Younger age (<60 years)** and **longer procedures (>45 minutes) 3
• Type of procedure: TURBT carries 4.35-fold increased risk; TURP carries 3.25-fold increased risk compared to simple cystoscopy 3

Advanced Therapies for Refractory Cases

When First-Line Treatments Fail

For OAB-related spasms not responding to oral medications 1:

1. Measure post-void residual (PVR) before escalating therapy

2. Intradetrusor botulinum toxin (BTX) injection:

   • Use caution if PVR >100-200 mL
   • Counsel patients about risk of incomplete emptying requiring clean intermittent catheterization
   • Reassess at 2 weeks post-injection with PVR measurement
   • Discontinue oral medications if BTX provides adequate response; restart only if symptoms recur 1

3. Sacral neuromodulation (SNM) or percutaneous tibial nerve stimulation (PTNS) 1

4. Urodynamic studies may be performed if patients fail both pharmacotherapy and minimally invasive therapies to exclude other disorders 1

Severe, Protracted Spasms

For neurogenic patients with severe, protracted bladder spasms unresponsive to conventional therapy:

• Intrathecal baclofen via implanted pump can provide prompt relief with bolus dosing and increased daily doses, particularly effective when spasms trigger autonomic dysreflexia 9

Last-Resort Options

Chronic indwelling catheters (urethral or suprapubic) should only be recommended when all OAB therapies are contraindicated, ineffective, or no longer desired 1:

• Suprapubic tubes are preferred over urethral catheters due to reduced urethral trauma risk
• Requires extensive shared decision-making about long-term complications (erosion, granulation tissue, bleeding)
• Ultrasound guidance mitigates placement risks (bowel perforation, vascular injury)

Critical Pitfalls to Avoid

• Do not rely on B&O suppositories for prophylaxis—evidence does not support efficacy 3
• Always measure PVR before BTX injection to avoid retention complications 1
• Do not continue oral medications unnecessarily after successful minimally invasive procedures—restart only if symptoms recur 1
• Recognize that intravesical chemotherapy/immunotherapy (BCG, newer agents like nadofaragene firadenovec) commonly causes irritative symptoms requiring proactive management 4